文献速递关节外科

伪装被揭开:接下来该怎么办?

Camouflage uncovered: what should happen next?
PubMed 文献 · Bone Joint J · 2023-03-01

近期有文献指出,部分品牌的关节置换假体可能包含性能显著更差(或更好)的变异型号。为此,英国国家关节登记中心对较大的膝关节置换家族进行了更详细的分析,以识别此前可能被隐藏的差异。对Nexgen膝关节假体品牌的分析发现,某些后稳定型组合的胫骨无菌性松动翻修率特别高,因此对涉及的Nexgen「option」胫骨部件发布了医疗器械召回。

要点

  • 部分关节置换品牌内不同变异型号的性能可能存在显著差异。
  • Nexgen膝关节假体中某些后稳定型组合的胫骨无菌性松动翻修率特别高。
  • 已对涉及的Nexgen「option」胫骨部件发布医疗器械召回。

核心结论

  • 常规需要更精细的信号检测方法,以识别密切相关的植入物类型之间的结果变异,从而保护患者免受此类结局差异的影响。

研究设计与样本

  • 本文为针对近期出版物及国家关节登记中心分析结果的述评。

主要发现

  • 对Nexgen膝关节假体品牌的分析发现,某些后稳定型组合的胫骨无菌性松动翻修率特别高。

关键数值与推荐

  • 国家关节登记中心对较大的膝关节置换家族进行了更详细的分析,以识别差异可能存在的具体位置。
  • 已对涉及的Nexgen「option」胫骨部件发布医疗器械召回。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent publications have drawn attention to the fact that some brands of joint replacement may contain variants which perform significantly worse (or better) than their 'siblings'. As a result, the National Joint Registry has performed much more detailed analysis on the larger families of knee arthroplasties in order to identify exactly where these differences may be present and may hitherto have remained hidden. The analysis of the Nexgen knee arthroplasty brand identified that some posterior-stabilized combinations have particularly high revision rates for aseptic loosening of the tibia, and consequently a medical device recall has been issued for the Nexgen 'option' tibial component which was implicated. More elaborate signal detection is required in order to identify such variation in results in a routine fashion if patients are to be protected from such variation in outcomes between closely related implant types.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Wilton T, Skinner JA, Haddad FS, et al. Camouflage uncovered: what should happen next? Bone Joint J. 2023. PMID: 36854320. doi:10.1302/0301-620X.105B3.BJJ-2023-0145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。